A cyclic peptide derived from α-fetoprotein inhibits the proliferative effects of the epidermal growth factor and estradiol in MCF7 cells

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1597-1603

  Torres, Cristian ^a   Antileo, Elmer ^a   Epuñán, María José ^a   Pino, Ana María ^a   Valladares, Luis Emilio ^a   Sierralta, Walter Daniel ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

fetoprotein; Cyclic peptide; Epidermal growth factor; Estradiol; Heparin binding epidermal growth factor; MCF7 cells

Indexed keywords

ALPHA FETOPROTEIN; CYCLOPEPTIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; GELATINASE A; GELATINASE B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; ESTROGEN; MATRIX METALLOPROTEINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CULTURE MEDIUM; FETAL CALF SERUM; GENE EXPRESSION REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CELL CULTURE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

ALPHA-FETOPROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGENS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES, CYCLIC; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 48849093305     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Russo J and Russo IH: The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102: 89-96, 2006.
2. McDonnel DP and Norris JD: Connections and regulation of the human estrogen receptor. Science 296: 1642-1644, 2002.
3. Simoncini T and Genazzani AR: Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148: 281-292, 2003.
4. Tesarik J and Mendoza C: Nongenomic effects of 17 ß-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 80: 1438-1443, 1995.
5. Aronica SM, Kraus WL and Katzenellenbogen BS: Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91: 8517-8522, 1994.
6. Le Mellay V, Grosse B and Lieberherr M: Phospholipase C ß and membrane action of calcitriol and estradiol. J Biol Chem 272: 11902-11907, 1997.
7. Lieberherr M, Grosse B, Kachkache M and Batsan S: Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional non-nuclear receptors. J Bone Miner Res 8: 1365-1376, 1993.
8. Kelly MJ and Levin ER: Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12: 152-156, 2001.
9. Filardo EJ, Quinn JA, Frackelton AR Jr and Bland KI: Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84, 2002.
10. Levin ER: Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17: 309-317, 2003.
11. Razandi M, Pedram A, Park ST and Levin ER: Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278: 2701-2712, 2003.
12. Zhang W and Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18, 2002.
13. Song RXD, Zhang ZH, Chen Y, Bao Y and Santen RJ: Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF7 breast cancer cells. Endocrinology 148: 4091-4101, 2007.
14. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM and Shaul PW: Plasma membrane estrogen receptors are coupled to endothelial nitric oxide synthase through Gα(i). J Biol Chem 276: 27071-27076, 2001.
15. Thiantanawat A, Long BJ and Brodie AM: Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. Cancer Res 63: 8037-9050, 2003.
16. Mesfin FB, Andersen TT, Jacobson HI, Zhu SJ and Bennett JA: Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer. J Pept Res 58: 246-256, 2001.
17. Bennett JA, Mesfin JA, Zhu SJ, Gierthy JF, Jacobson III and Andersen TT: A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen. Proc Natl Acad Sci USA 99: 2211-2215, 2002.
18. DeFreest LA, Mesfin FB, Joseph L, McLeod DJ, Stallmer A, Reddy S, Balulad SS, Jacobson HI, Andersen TT and Bennett JA: Synthethic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization. J Pept Res 63: 409-419, 2004.
19. Bennett JA, DeFreest L, Anaka I, Saadati H, Balulad S, Jacobson HI and Andersen TT: AFPep: an anti-breast cancer peptide that is orally active. Breast Cancer Res Treat 98: 133-141, 2006.
20. Sierralta WD, Epuñan MJ, Reyes JM, Valladares LE, Andersen TT, Bennett JA, Jacobson HI and Pino AM: A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture. Oncol Rep 19: 229-235, 2008.
21. Ahmad T, Farnie G, Bundred NJ and Anderson NG: The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem 279: 1713-1719, 2004.
22. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R and McCubrey JA: Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol 22: 469-480, 2003.
23. Roovers K and Assoian RK: Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22: 818-826, 2000.
24. Ram TG, Kokeny KE, Dilts CA and Ethier SP: Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. J Cell Physiol 163: 589-596, 1995.
25. Thomas M: Overview of clinical trials with epidermal growth factor receptor inhibitors in advanced non-small cell lung cancer. Semin Oncol Nurs 18: 20-27, 2002.